Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant Long-Term Safety in Pruritus
NCT03540160Phase 3Terminated
- Sponsor
- Vyne Therapeutics
- Start
- Mar 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of serlopitant in pruritus, sponsored by Vyne Therapeutics. Started Mar 2018; status: terminated.
02
Drugs
serlopitant
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT03540160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540160.